Head & Neck Oncology · 2009 · 82 citations · 60 references
DentistryOncologyOral PathologyMaxillofacial PathologyOral MicrobiologyOral OncologyHuman Papillomavirus InfectionOncogenic VirusesOral CarcinogenesisOral Cavity CancerOral NeoplasiaOral Viral InfectionsHpv PathogenesisHpv TransmissionHuman Papillomavirus PrognosisHuman Papillomavirus StatusHuman Papillomavirus-associated Oral CancerMucosal Human Papillomavirus InfectionOral Human Papillomavirus InfectionProphylactic Cancer Vaccines
Head & Neck Cancer (HNC) represents the sixth most common malignancy worldwide and it is historically linked to well-known behavioural risk factors, i.e., tobacco smoking and/or the alcohol consumption. Recently, substantial evidence has been mounting that Human Papillomavirus (HPV) infection is playing an increasing important role in oral cancer. Because of the attention and clamor surrounding oral HPV infection and related cancers, as well as the use of HPV prophylactic vaccines, in this invited perspective the authors raise some questions and review some controversial issues on HPV infection and its role in HNC, with a particular focus on oral squamous cell carcinoma. The problematic definition and classification of HNC will be discussed, together with the characteristics of oral infection with oncogenic HPV types, the frequency of HPV DNA detection in HNC, the location of HPV-related tumours, the severity and prognosis of HPV-positive HNC, the diagnosis of oral HPV infection, common routes of oral infection and the likelihood of oro-genital HPV transmission, the prevention of HPV infection and novel therapeutic approaches.
60
Estimating the world cancer burden: Globocan 2000
D. Maxwell Parkin, Freddie Bray, Jacques Ferlay et al. · International Journal of Cancer · 2001 · 3.7K citations · Full text
Diane M. Harper, Eduardo L. Franco, Cosette M. Wheeler et al. · The Lancet · 2006 · 1.6K citations · Full text